Outcomes 6-Months Postintervention (Per Protocol Analysis), Female Patients
| Outcomes | No./Total No. (%) | Absolute Difference, % (95% CI) | P Value* | |
|---|---|---|---|---|
| Reminder Letter (n = 1459) | Reminder Phone Call (n = 977) | |||
| Patients who received at least one screening test for which they were due | 370/1459 (25.4) | 395/977 (40.4) | 15.1 (11.3–18.9) | <.001 |
| Patients overdue for a Pap test who received a Pap test | 241/1029 (23.4) | 269/653 (41.2) | 17.8 (13.2–22.4) | <.001 |
| Patients overdue for a mammogram who received a mammogram | 72/441 (16.3) | 72/315 (22.9) | 6.5 (3.0–12.3) | .024 |
| Patients overdue for CRC screening who received a CRC screen | 84/464 (18.1) | 81/339 (23.9) | 5.8 (0.1–11.5) | .045 |
| Patients overdue for CRC screening who receive an FOBT | 69/464 (14.9) | 72/339 (21.2) | 6.4 (0.9–11.8) | .019 |
| Patients overdue for CRC screening who receive a colonoscopy | 18/464 (3.9) | 14/339 (4.1) | 0.3 (−2.5 to 3.0) | .858 |
↵* χ2 test.
CRC, colorectal cancer; CI, confidence interval; FOBT, fecal occult blood test.